Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods

• US 6,503,198 B1
• Filed: 09/11/1997
• Issued: 01/07/2003
• Est. Priority Date: 09/11/1997
• Status: Expired due to Fees

• Current Assignee: Technical Chemicals & Products Incorporated
• Original Assignee: Technical Chemicals & Products Incorporated
• Inventors: Mitchen, Joel R., Aronowtiz, Jack L.
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US08/929,262
• Time in Patent Office: 1,944 Days
• Field of Search: 600/309, 600/362, 600/364, 600/365, 600/367, 600/573, 600/584
• US Class Current: 600/365
• CPC Class Codes: A61B 10/0035 Vaccination diagnosis other than by injuring the skin, e.g. allergy test patches
• CPC Class Codes: A61B 2010/008 Interstitial fluid
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: G01N 33/66 involving blood sugars, e.g. galactose
• CPC Class Codes: G01N 33/94 involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Abstract

The present invention relates to noninvasive transdermal systems and methods for analyte extraction from a biological fluid within or beneath the skin, such as interstitial fluid, and detection of the analyte. More particularly, the present invention relates to noninvasive transdermal patches comprised of a wet chemistry component and a dry chemistry component. The wet chemistry component is a liquid transfer medium in the form of a gel layer for the extraction and liquid bridge transfer of the analyte of interest from the biological fluid within or beneath the skin to the dry chemistry component. The dry chemistry component is a super sensitive or conditioned membrane carrying a reagent system for interacting with the analyte of interest to generate an indicator molecule, e.g., color change, to confirm detection of the analyte, and methods of use thereof. The indicator molecule may be visually observed by the individual user or observed by an electronic interpretation component, such as a reflectance spectrophotometer for detection. A particular analyte of interest which may be detected accurately, reliably and quantitatively in accordance with the present invention is glucose. The noninvasive transdermal systems of the present invention are low in-cost and suitable for convenient use by non-medical personnel.

Claims

1. A noninvasive transdermal system for detecting an analyte in extracted from or underneath the skin of a subject, said noninvasive transdermal system comprising:

a dry chemistry component for interacting with the analyte, said dry chemistry component having a sensitivity which enables it to detect the analyte extracted from or underneath the skin within about 6 minutes or less following application of said noninvasive transdermal system to the skin of the subject, and

a wet chemistry component for wetting said dry chemistry component and for transferring the analyte from or underneath the skin to said dry chemistry component in an amount sufficient, so that said dry chemistry component can detect the analyte within about about 6 minutes or less following application of said noninvasive transdermal system to the skin of the subject, wherein said dry chemistry component and said wet chemistry component are stored separate from one another prior to application of said noninvasive transdermal system to the skin of the subject, and wherein said dry chemistry component is in communication with said wet chemistry component following application of said noninvasive transdermal system to the skin of the subject, so that said wet chemistry component can continuously wet said dry chemistry component while said noninvasive transdermal system is applied to the skin of the subject to enable the analyte to interact with the wetted dry chemistry component.

2. A noninvasive transdermal system of claim 1 where said wet chemistry component is a gel.

3. A noninvasive transdermal system of claim 2 wherein said gel comprises carboxy polymethylene and propylene glycol.

4. A noninvasive transdermal system of claim 2 wherein said gel consists essentially of about 1% carboxy polymethylene and about 10% propylene glycol.

51. A noninvasive transdermal system of claim 2, wherein said gel is present in an amount of about 25 mcls.

52. A noninvasive transdermal system of claim 1, wherein said noninvasive transdermal system has the ability to detect the analyte in a concentration which is at least as low as about 5 mcg/ml.

53. A noninvasive transdermal system of claim 1, wherein the biological fluid is interstitial fluid.

54. A noninvasive transdermal system of claim 1, wherein the analyte is glucose.

5. A non-toxic and non-flammable, noninvasive transdermal system for detecting an analyte which has diffused from or underneath the skin of a subject, said noninvasive transdermal system comprising:

a single layered dry chemistry component for interacting with the analyte to detect the analyte, said dry chemistry component having a sensitivity which enables it to detect the analyte diffused from the biological fluid within about 15 minutes or less following application of said noninvasive transdermal system to the skin of the subject, and

a single layered wet chemistry component for transferring the analyte from or underneath the skin to said dry chemistry component in an amount sufficient, so that said dry chemistry component can detect the analyte within about 15 minutes or less following application of said noninvasive transdermal system to the skin of the subject, wherein said single layered dry chemistry component and said single layered wet chemistry component are stored separate from one another prior to application of said noninvasive transdermal system to the skin of the subject, and wherein said single layered dry chemistry component is in communication with said single layered wet chemistry component following application of said noninvasive transdermal system to the skin of the subject, so that said single layered wet chemistry component can continuously wet said single layered dry chemistry component while said noninvasive transdermal system is applied to the skin of the subject.

6. A noninvasive transdermal system of claim 5 wherein the biological fluid is interstitial fluid.

7. A noninvasive transdermal system of claim 5 wherein the analytic is glucose.

8. A noninvasive transdermal system of claim 5 wherein said wet chemistry component is a gel which includes carboxy polymethylene and propylene glycol.

47. A noninvasive transdermal system of claim 5, wherein said detection occurs within about 4 to about 6 minutes or less.

48. A noninvasive transdermal system of claim 5, wherein said wet chemistry component is a gel.

50. A noninvasive transdermal system of claim 5, wherein said noninvasive transdermal system has the ability to detect the analyte in a concentration which is at least as low as about 5 mcg/ml.

9. A noninvasive transdermal patch for detecting an analyte extracted from or underneath the skin of a subject, said noninvasive transdermal patch comprising:

a first housing having a dry chemistry component for interacting with the analyte, said dry chemistry component having a sensitivity for reliable detection and quantification of the analyte, when wetted, which enables it to detect the analyte extracted from or underneath the skin of a subject, said first housing having an outer top surface and an inner bottom, surface and an aperture therethrough in which said dry chemistry component is adapted to be positioned permit the analyte to interact with the dry chemistry component when wetted, so that the interaction between the analyte and said dry chemistry component, when wetted, can be visualized and the analyte can be detected;

a second housing having a wet chemistry component for wetting said dry chemistry component and for transferring the analyte from or underneath the skin to said dry chemistry component in an amount sufficient, so that said dry chemistry component, when wetted, can interact with the analyte to detect the analyte, said second housing having an inner top surface and an outer bottom surface and an aperture therethrough in which said wet chemistry component is adapted to be positioned;

said noninvasive transdermal patch having an unassembled form prior to application of wherein noninvasive transdermal patch to the skin of the subject, said first and second housings are stored separate from one another; and

whereby, when said noninvasive transdermal patch is in an assembled form, said inner top surface of said second housing is positioned adjacent said inner bottom surface of said first housing and said outer bottom surface of said second housing of said noninvasive transdermal patch is positioned against the skin of the subject, so that said wet chemistry component is in continuous contact with both the skin and said dry chemistry component during use to enable said wet chemistry component to wet said dry chemistry component and to transfer the analyte in the biological fluid extracted from or underneath the skin of a subject to said wetted dry chemistry component to enable the analyte to interact with said wetted dry chemistry component, so that the analyte can be reliably and quantitatively detected within about 15 minutes or less following the positioning of said assembled noninvasive transdermal patch against the skin of the subject and while said noninvasive transdermal patch is positioned on the skin of the subject.

10. A noninvasive transdermal patch of claim 9, wherein said first and second housings are comprised of a moisture-impervious, cross-linked closed cell sponge.

11. A noninvasive transdermal patch of claim 10, wherein said moisture-impervious, cross-linked closed cell sponge is a polyethylene foam.

12. A noninvasive transdermal patch of claim 9, wherein said noninvasive transdermal patch, when in an unassembled form, further includes an outer top pulltab layer removably positioned on the inner bottom surface of said first housing and the inner top surface of said second housing.

13. A noninvasive transdermal patch of claim 12, wherein a pressure sensitive adhesive is affixed to one surface of said outer top pull tab, so that said outer top pull tab can be removably positioned adjacent the inner bottom surface of said first housing and the inner top surface of said second housing.

14. A noninvasive transdermal patch of claim 9, wherein said noninvasive transdermal patch further includes a moisture-impervious sheet positioned adjacent the outer top surface of said first housing and the outer bottom surface of said second housing, said moisture-impervious sheet including first and second through-holes, wherein the first through-hole is in alignment with the aperture in said first housing and the second through-hole is in alignment with the aperture in said second housing.

15. A noninvasive transdermal patch of claim 14, wherein said moisture-impervious sheet has top and bottom surfaces and a pressure sensitive adhesive affixed to both said top and bottom surfaces of said moisture-impervious sheet.

16. A noninvasive transdermal patch of claim 9, wherein said noninvasive transdermal patch, when in an unassembled form, further includes an outer bottom pulltab layer removably positioned on said moisture-impervious sheet.

17. A noninvasive transdermal patch of claim 9, wherein the skin of the subject is the right or left volar skin portion of the forearm of the subject.

18. A noninvasive transdermal patch of claim 9, wherein said dry chemistry component includes dry chemical reagents for reaction with the analyte to release or form a reporter or indicator molecule, which is indicative of the presence of the analyte in the biological fluid, so that the analyte can be reliably and quantitatively detected.

19. A noninvasive transdermal patch of claim 18, wherein said first housing includes a membrane conditioned with the dry chemical reagents.

20. A noninvasive transdermal patch of claim 19, wherein said membrane is comprised of a polyether sulfone.

21. A noninvasive transdermal patch of claim 18, wherein the dry chemical reagents include an enzyme and a chromophore.

22. A noninvasive transdermal patch of claim 18, wherein the dry chemical reagents include a chromophore, an enzyme, peroxidase, albumin, polyvinyl pyrrolidinone, dioctylsulfosuccinate and 2-butendioic acid.

23. A noninvasive transdermal patch of claim 21, wherein the chromophore is O-tolidine.

24. A noninvasive transdermal patch of claim 22, wherein the chromophore is O-tolidine.

25. A noninvasive transdermal patch of claim 21, wherein the chromophore is tetra-methyl benzidine.

26. A noninvasive transdermal patch of claim 22, wherein the chromophore is tetra-methyl benzidine.

27. A noninvasive transdermal patch of claim 21, wherein the enzyme is glucose oxidase.

28. A noninvasive transdermal patch of claim 22, wherein the enzyme is glucose oxidase.

29. A noninvasive transdermal patch of claim 21, wherein the enzyme is cholesterol oxidase and cholesterol esterase.

30. A noninvasive transdermal patch of claim 22, wherein the enzyme is cholesterol oxidase and cholesterol esterase.

31. A noninvasive transdermal patch of claim 9, wherein the analyte is glucose.

32. A noninvasive transdermal patch of claim 9, wherein the analyte is cholesterol.

33. A noninvasive transdermal patch of claim 9, wherein the analyte is selected from the group consisting of a triglyceride, bilirubin, creatinine, urea, alpha-amylase, lactate, lactic acid, alanine aminotransferase (ALT/GPT), aspartate aminotransferase (AST/GOT), albumin, uric acid, fructose amine, potassium, sodium, chloride, pyruvate dehydrogenase, phenylalaninehydroxylase, purine nucleotide enzymes and phenylalanine hydroxylase, phenyl-alanine, phenyl-pyruvate and phenyl-lactate.

34. A noninvasive transdermal patch of claim 9, wherein said detection occurs within about 3 to about 15 minutes or less.

35. A noninvasive transdermal patch of claim 9, wherein said detection occurs within about 4 to about 6 minutes or less.

36. A noninvasive transdermal patch of claim 9 wherein said wet chemistry component is a gel.

37. A noninvasive transdermal patch of claim 32 wherein said gel is a hydrophobic gel.

38. A noninvasive transdermal patch of claim 32 wherein said gel includes carboxy polymethylene.

39. A noninvasive transdermal patch of claim 32 wherein said gel includes a skin permeation enhancer.

40. A noninvasive transdermal patch of claim 35 wherein said skin permeation enhancer is propylene glycol.

41. A noninvasive transdermal patch of claim 32 wherein said gel comprises carboxy polymethylene and propylene glycol.

42. A noninvasive transdermal patch of claim 32 wherein said gel consists essentially of about 1% carboxy polymethylene and about 10% propylene glycol.

43. A noninvasive transdermal patch of claim 32 wherein said gel is present in said second housing in an amount of between about 20 mcls and 35 mcls.

44. A noninvasive transdermal patch of claim 32 wherein said gel is present in said second housing in an amount of about 25 mcls.

45. A noninvasive transdermal patch of claim 9, wherein said noninvasive transdermal patch has the ability to detect an analyte in a concentration which is at least as low as about 5 mcg/ml.

46. A noninvasive transdermal patch of claim 9, wherein the biological fluid is interstitial fluid.

49. A noninvasive transdermal system of claim 44, wherein said gel is present in an amount of about 25 mcls.